We are live on
!
Find out more
Sanders Capital Portfolio holdings
AUM
$83.9B
1-Year Est. Return
37.89%
This Fund
S&P 500
This Quarter
Est. Return
+3.76%
1 Year Est. Return
+37.89%
3 Year Est. Return
+120.64%
5 Year Est. Return
+154.21%
10 Year Est. Return
+678.77%
AUM
$22.3B
AUM Growth
+$512M
(+2.4%)
Cap. Flow
-$87.8M
Cap. Flow
% of AUM
-0.39%
Top 10 Holdings %
Top 10 Hldgs %
54.73%
Holding
40
New
–
Increased
14
Reduced
22
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$185M |
| 2 |
Elevance Health
ELV
|
+$27.2M |
| 3 |
Citigroup
C
|
+$19.8M |
| 4 |
Bank of America
BAC
|
+$18.7M |
| 5 |
Cigna
CI
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$173M |
| 2 |
D.R. Horton
DHI
|
+$55.2M |
| 3 |
TSMC
TSM
|
+$47.2M |
| 4 |
Apple
AAPL
|
+$46.5M |
| 5 |
Gilead Sciences
GILD
|
+$21.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.29% |
| 2 | Healthcare | 20.61% |
| 3 | Financials | 15.87% |
| 4 | Communication Services | 13.04% |
| 5 | Consumer Discretionary | 8.47% |
Similar funds
Sanders Capital's Q3 2019 Portfolio in Review
As of Q3 2019, Sanders Capital held 40 positions worth $22.3B, up 2.4% from $21.8B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Trading was light in Q3 2019: portfolio turnover was 0%. Sanders Capital opened no new positions and made no exits, leaving the 40-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Sanders Capital added most to Pfizer in Q3 2019, an estimated $185M increase.
- Sanders Capital's biggest Q3 2019 reduction was Merck, cutting an estimated $173M.
- Sanders Capital's ten largest holdings make up 55% of its $22.3B portfolio in Q3 2019.
- Sanders Capital opened 0 new positions and closed 0 in Q3 2019.
- Sanders Capital's portfolio value rose 2.4% quarter-over-quarter to $22.3B.
Based on Sanders Capital's 13F filing for Q3 2019, filed 13 Nov 2019.